Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2011 Apr 7;123(7):209–214. doi: 10.1007/s00508-011-1557-8

A surge of flu-associated adult respiratory distress syndrome in an Austrian tertiary care hospital during the 2009/2010 Influenza A H1N1v pandemic

Schweres Influenza-assoziiertes Lungenversagen in einem österreichischen Tertiärkrankenhaus während der 2009/2010 Influenza A H1N1v Pandemie

Peter Schellongowski 1, Roman Ullrich 2, Cornelia Hieber 2, Hubert Hetz 2, Heidrun Losert 3, Maria Hermann 1, Alexander Hermann 1, Klaus-Bernhard Gattringer 1, Viktoria Siersch 1, Werner Rabitsch 1, Valentin Fuhrmann 4, Andja Bojic 1, Oliver Robak 1, Wolfgang R Sperr 1, Klaus Laczika 1, Gottfried J Locker 1, Thomas Staudinger 1,✉
PMCID: PMC7101632  PMID: 21465083

Summary

We report on 17 patients with influenza A H1N1v-associated Adult Respiratory Distress Syndrome who were admitted to the intensive care unit (ICU) between June 11th 2009 and August 10th 2010 (f/m: 8/9; age: median 39 (IQR 29–54) years; SAPS II: 35 (29–48)). Body mass index was 26 (24–35), 24% were overweight and 29% obese. The Charlson Comorbidity Index was 1 (0–2) and all but one patient had comorbid conditions. The median time between onset of the first symptom and admission to the ICU was 5 days (range 0–14). None of the patients had received vaccination against H1N1v. Nine patients received oseltamivir, only two of them within 48 hours of symptom onset. All patients developed severe ARDS (PaO2/FiO2-Ratio 60 (55–92); lung injury score 3.8 (3.3–4.0)), were mechanically ventilated and on vasopressor support. Fourteen patients received corticosteroids, 7 patients underwent hemofiltration, and 10 patients needed extracorporeal membrane-oxygenation (ECMO; 8 patients veno-venous, 2 patients veno-arterial), three patients Interventional Lung Assist (ILA) and two patients pump driven extracorporeal low-flow CO2-elimination (ECCO2–R). Seven of 17 patients (41%) died in the ICU (4 patients due to bleeding, 3 patients due to multi-organ failure), while all other patients survived the hospital (59%). ECMO mortality was 50%. The median ICU length-of-stay was 26 (19–44) vs. 21 (17–25) days (survivors vs. nonsurvivors), days on the ventilator were 18 (14–35) vs. 20 (17–24), and ECMO duration was 10 (8–25) vs. 13 (11–16) days, respectively (all p = n.s.). Compared to a control group of 241 adult intensive care unit patients without H1N1v, length of stay in the ICU, rate of mechanical ventilation, days on the ventilator, and TISS 28 scores were significantly higher in patients with H1N1v. The ICU survival tended to be higher in control patients (79 vs. 59%; p = 0.06). Patients with H1N1v admitted to either of our ICUs were young, overproportionally obese and almost all with existing comorbidities. All patients developed severe ARDS, which could only be treated with extracorporeal gas exchange in an unexpectedly high proportion. Patients with H1N1v had more complicated courses compared to control patients.

Keywords: H1N1, Respiratory failure, ARDS, ECMO, TISS 28, SAPS II

References

  1. ANZIC Influenza Investigators. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925–1934. doi: 10.1056/NEJMoa0908481. [DOI] [PubMed] [Google Scholar]
  2. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880–1887. doi: 10.1001/jama.2009.1536. [DOI] [PubMed] [Google Scholar]
  3. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med. 2009;361(20):1935–1944. doi: 10.1056/NEJMoa0906695. [DOI] [PubMed] [Google Scholar]
  4. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872–1879. doi: 10.1001/jama.2009.1496. [DOI] [PubMed] [Google Scholar]
  5. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American–European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
  6. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care. 2009;13(5):R148. doi: 10.1186/cc8044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Freed DH, Henzler D, White CW, Fowler R, Zarychanski R, Hutchison J, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth. 2010;57(3):240–247. doi: 10.1007/s12630-009-9253-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA. 2009;302(17):1888–1895. doi: 10.1001/jama.2009.1535. [DOI] [PubMed] [Google Scholar]
  9. Baldanti F, Campanini G, Piralla A, Rovida F, Braschi A, Mojoli F, et al. Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. Clin Microbiol Infect 2010 Oct 14. doi: 10.1111/j.1469-0691.2010.03403.x [DOI] [PubMed]
  10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8. [DOI] [PubMed] [Google Scholar]
  11. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963. doi: 10.1001/jama.270.24.2957. [DOI] [PubMed] [Google Scholar]
  12. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  13. Miranda DR, de Rijk A, Schaufeli W. Simplified Therapeutic Intervention Scoring System: the TISS-28 items. Results from a multicenter study. Crit Care Med. 1996;24(1):64–73. doi: 10.1097/00003246-199601000-00012. [DOI] [PubMed] [Google Scholar]
  14. Moreno R, Morais P. Validation of the simplified therapeutic intervention scoring system on an independent database. Intensive Care Med. 1997;23(6):640–644. doi: 10.1007/s001340050387. [DOI] [PubMed] [Google Scholar]
  15. Gattinoni L, Pesenti A, Masceroni D, Marcolin R, Fumagalli R, Rossi F, et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986;256(7):881–886. doi: 10.1001/jama.256.7.881. [DOI] [PubMed] [Google Scholar]
  16. The acute respiratory distress syndrome network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. N Engl J Med. 2000;342(18):1301–1308. doi: 10.1056/NEJM200005043421801. [DOI] [PubMed] [Google Scholar]
  17. Roch A, Lepaul-Ercole R, Grisoli D, Bessereau J, Brissy O, Castanier M, et al. Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study. Intensive Care Med. 2010;36(11):1899–1905. doi: 10.1007/s00134-010-2021-3. [DOI] [PubMed] [Google Scholar]
  18. Estenssoro E, Ríos FG, Apezteguía C, Reina R, Neira J, Ceraso DH, et al. Registry of the Argentinian Society of Intensive Care SATI. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med. 2010;182(1):41–48. doi: 10.1164/201001-0037OC. [DOI] [PubMed] [Google Scholar]
  19. Trimarchi H, Greloni G, Campolo-Girard V, Giannasi S, Pomeranz V, San-Roman E, et al. H1N1 infection and the kidney in critically ill patients. J Nephrol 2010. may. 22. (in press) [PubMed]
  20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi: 10.1097/00003246-198510000-00009. [DOI] [PubMed] [Google Scholar]
  21. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793–1800. doi: 10.1097/00003246-199811000-00016. [DOI] [PubMed] [Google Scholar]
  22. Graf J, Graf C, Koch KC, Hanrath P, Janssens U. Cost analysis and outcome prediction with the Therapeutic Intervention Scoring System (TISS and TISS-28) Med Klin (Munich) 2003;98(3):123–132. doi: 10.1007/s00063-003-1235-3. [DOI] [PubMed] [Google Scholar]
  23. Strauss R, Muchl R, El Belazi G, Hain C, Hrabcik H. Neue Influenza A(H1N1) – Status quo März 2010. Available from: http://www.bmg.gv.at/cms/site/attachments/7/9/4/CH0954/CMS1268583914358/h1n1maerz22032009.pdf
  24. Hota S, Fried E, Burry L, Stewart TE, Christian MD. Preparing your intensive care unit for the second wave of H1N1 and future surges. Crit Care Med. 2010;38(4 Suppl.):e110–e119. doi: 10.1097/CCM.0b013e3181c66940. [DOI] [PubMed] [Google Scholar]

Articles from Wiener Klinische Wochenschrift are provided here courtesy of Nature Publishing Group

RESOURCES